The pharmaceutical revolution that gathered pace in the 1930s
delivered a plethora of almost magical new drugs such as penicillin,
streptomycin, cortisone, and the birth control pill. This revolution
grew from academic-business relationships in five countries: USA,
Germany, Great Britain, Switzerland, and France. Many other countries
tried and failed to replicate this success, yet a handful of
Scandinavia companies made important breakthroughs in a narrow band of
specialities. This is the story of how one Norwegian company—
Nyegaard & Co. —achieved international success from the 1970s
onwards with a breakthrough product facilitating X-ray pictures of the
soft tissues of the body. The company succeeded by harnessing research
skills and creating scientific and business alliances abroad, building
its own momentum step by step: the corporation as entrepreneur. It
thereby broke with the conventional way a national medical ecosystem
facilitated the crucial scientific progress. This is a story both of
personal initiatives and great organizational transformations in
several stages. In the 1950s, Nyegaard & Co. was a small hierarchical
home market-oriented generics company. By the end of the 1990s, it had
developed into a fairly large and multinational hierarchical company,
preoccupied as much with shareholder value as scientific progress. It
has also become a company that no longer had the same ability to
innovate as before and therefore became merged into another one.
Les mer
Produktdetaljer
ISBN
9780192695598
Publisert
2022
Utgiver
Vendor
OUP Oxford
Språk
Product language
Engelsk
Format
Product format
Digital bok
Forfatter